News|Articles|November 13, 2023
Expert Discussion Series - Multi-Attribute Methods - How Accessible is MAM to Routine Laboratories?
Author(s)Waters
Can you really deploy a Multiple-Attribute Method in a routine lab? Hear from experts across the industry in volume 4 of our Expert Discussion Series.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
2
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
3
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
4
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
5